semaglutide and anesthesia New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Risks GLP-1 semaglutide anesthesia endoscopy

Patient stratification probably matters more than any single drug choice, because the variable results likely conceal responder subgroups

Providers can use biomarker context and clinical history to anticipate and mitigate this potential adverse effect

Slides were kept overnight at R, and images were taken using a Keyence fluorescence microscope (Keyence, BZ-X800/ BZ-X810) with a 40x or 100x objective

10.1046/j.1365-201X.2001.00820.x

Semaglutide is currently being investigated in two large phase III clinical trial programs for treating obesity: the STEP program, which aims to obtain regulatory approval for semaglutide as an anti-obesity drug and is evaluating cardiovascular outcomes in 17,500 patients

Some providers recommend administering BPC-157 in traditional subcutaneous injection sites such as the abdomen or thigh